#URGENT
NBEMS has given final opportunity for candidates who need to change the rejected images in application form.
Attaching a list of candidates whose images are rejected.
https://natboard.edu.in/viewUpload?xyz=ZWVrRHI0SkZ6WFVkZDhXWmdySkpzdz09
https://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
NBEMS has given final opportunity for candidates who need to change the rejected images in application form.
Attaching a list of candidates whose images are rejected.
https://natboard.edu.in/viewUpload?xyz=ZWVrRHI0SkZ6WFVkZDhXWmdySkpzdz09
https://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
โค2
*Important: NEET PG 2026 CITY ALLOTMENT*
The message everyone is getting is wrong. Don't worry.
Login & see the allotted city, that's the correct one.
People are getting random messages. Ignore.
Login here https://cdn3.digialm.com/EForms/configuredHtml/1815/94357/login.html
The message everyone is getting is wrong. Don't worry.
Login & see the allotted city, that's the correct one.
People are getting random messages. Ignore.
Login here https://cdn3.digialm.com/EForms/configuredHtml/1815/94357/login.html
๐2โค1
๐ฎ๐ณ๐๐ฒ๐ฟ๐ฒ๐ฏ๐ฒ๐น๐น๐๐บ 10% ๐ข๐ณ๐ณ๐ฒ๐ฟ๐ฎ๐ณ
โ ๐๐ผ๐๐ฝ๐ผ๐ป ๐๐ผ๐ฑ๐ฒ - MAGICBTR
โก๏ธ๐ ๐ถ๐๐๐ถ๐ผ๐ป 200+ ๐๐ ๐๐
โช๏ธ๐ก๐ฒ๐ ๐๐ฎ๐๐ฐ๐ต ๐ฆ๐๐ฎ๐ฟ๐๐ถ๐ป๐ด ๐๐ฟ๐ผ๐บ 21๐๐ ๐๐๐ด, 2026
โซ๏ธ6 ๐ ๐ผ๐ป๐๐ต๐ ๐ฃ๐น๐ฎ๐ป ๐ฃ๐ฟ๐ถ๐ฐ๐ฒ - 22,500/-
โซ๏ธ12 ๐ ๐ผ๐ป๐๐ต๐ ๐ฃ๐น๐ฎ๐ป ๐ฃ๐ฟ๐ถ๐ฐ๐ฒ - 30,600/-
๐๐ข๐ณ๐ณ๐ฒ๐ฟ ๐ถ๐ ๐๐ฎ๐น๐ถ๐ฑ ๐๐ถ๐น๐น 17๐๐ต ๐๐๐ด๐๐๐
๐ธ๐ ๐ฎ๐ธ๐ฒ ๐ฝ๐ฎ๐๐บ๐ฒ๐ป๐ ๐๐ต๐ฟ๐ผ๐๐ด๐ต ๐๐ฒ๐ฏ๐๐ถ๐๐ฒ
https://dashboard.cerebellumacademy.com/plans
โ๏ธ๐จ๐๐ฒ ๐๐ผ๐๐ฝ๐ผ๐ป ๐๐ผ๐ฑ๐ฒ - MAGICBTR
+917232021140
โ ๐๐ผ๐๐ฝ๐ผ๐ป ๐๐ผ๐ฑ๐ฒ - MAGICBTR
โก๏ธ๐ ๐ถ๐๐๐ถ๐ผ๐ป 200+ ๐๐ ๐๐
โช๏ธ๐ก๐ฒ๐ ๐๐ฎ๐๐ฐ๐ต ๐ฆ๐๐ฎ๐ฟ๐๐ถ๐ป๐ด ๐๐ฟ๐ผ๐บ 21๐๐ ๐๐๐ด, 2026
โซ๏ธ6 ๐ ๐ผ๐ป๐๐ต๐ ๐ฃ๐น๐ฎ๐ป ๐ฃ๐ฟ๐ถ๐ฐ๐ฒ - 22,500/-
โซ๏ธ12 ๐ ๐ผ๐ป๐๐ต๐ ๐ฃ๐น๐ฎ๐ป ๐ฃ๐ฟ๐ถ๐ฐ๐ฒ - 30,600/-
๐๐ข๐ณ๐ณ๐ฒ๐ฟ ๐ถ๐ ๐๐ฎ๐น๐ถ๐ฑ ๐๐ถ๐น๐น 17๐๐ต ๐๐๐ด๐๐๐
๐ธ๐ ๐ฎ๐ธ๐ฒ ๐ฝ๐ฎ๐๐บ๐ฒ๐ป๐ ๐๐ต๐ฟ๐ผ๐๐ด๐ต ๐๐ฒ๐ฏ๐๐ถ๐๐ฒ
https://dashboard.cerebellumacademy.com/plans
โ๏ธ๐จ๐๐ฒ ๐๐ผ๐๐ฝ๐ผ๐ป ๐๐ผ๐ฑ๐ฒ - MAGICBTR
+917232021140
โค2
๐ฅ ๐ก๐๐๐ง ๐ฃ๐ ๐ฎ๐ฌ๐ฎ๐ฒ โ ๐ญ๐ฑ ๐๐๐ฌ๐ฆ ๐๐๐๐ง ๐ฅ
๐ฏ ๐ฏ๐ฐ๐ฎ๐ฏ-๐๐ฐ๐ฌ๐ณ๐ซ ๐น๐ฌ๐ฝ๐ฐ๐บ๐ฐ๐ถ๐ต ๐บ๐ฌ๐น๐ฐ๐ฌ๐บ
๐ ๐ฆ๐๐ง ๐ญ/๐ณ โ ๐ญ๐ฑ ๐ ๐จ๐ฆ๐ง-๐ฅ๐๐ฉ๐๐ฆ๐ ๐ง๐ข๐ฃ๐๐๐ฆ
โโโโโโโโโโโโโโโโโโ
๐ซ ๐๐๐ก๐๐ฅ๐๐ ๐ ๐๐๐๐๐๐ก๐
โ ๐๐๐ + ๐๐ฟ๐ฟ๐ต๐๐๐ต๐บ๐ถ๐ฎ๐
โ ๐ฌ๐ช๐ฎ ๐๐๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐ / ๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐
โก ๐๐๐ฆ + ๐ ๐๐ผ๐ฐ๐ฎ๐ฟ๐ฑ๐ถ๐ฎ๐น ๐๐ป๐ณ๐ฎ๐ฟ๐ฐ๐๐ถ๐ผ๐ป
โ ๐ฌ๐ช๐ฎ ๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐
โข ๐๐ฒ๐ฎ๐ฟ๐ ๐๐ฎ๐ถ๐น๐๐ฟ๐ฒ
โ ๐๐๐ฟ๐๐ / ๐๐๐ฝ๐๐ + ๐ฑ๐ฟ๐๐ด๐ + ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐
โฃ ๐ฉ๐ฎ๐น๐๐๐น๐ฎ๐ฟ ๐๐ฒ๐ฎ๐ฟ๐ ๐๐ถ๐๐ฒ๐ฎ๐๐ฒ
โ ๐ด๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐
โค ๐ฆ๐๐ฟ๐ผ๐ธ๐ฒ + ๐๐ผ๐ฐ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป
โ ๐จ๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐
๐ฉบ ๐ฆ๐จ๐ฅ๐๐๐ฅ๐ฌ
โฅ ๐ฆ๐ต๐ผ๐ฐ๐ธ + ๐๐น๐๐ถ๐ฑ & ๐๐น๐ฒ๐ฐ๐๐ฟ๐ผ๐น๐๐๐ฒ ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐
โ ๐ป๐๐๐๐ ๐๐ ๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐๐
โฆ ๐ง๐ฟ๐ฎ๐๐บ๐ฎ + ๐๐ง๐๐ฆ
โ ๐ท๐๐๐๐๐๐ ๐๐๐๐๐๐ + ๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐
โง ๐๐๐ฟ๐ป๐
โ ๐ป๐ฉ๐บ๐จ + ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐๐๐
๐ฉ๐ปโโ๏ธ ๐ข๐๐ฆ๐ง๐๐ง๐ฅ๐๐๐ฆ & ๐๐ฌ๐ก๐๐๐๐ข๐๐ข๐๐ฌ
โจ ๐ฃ๐ผ๐๐๐ฝ๐ฎ๐ฟ๐๐๐บ ๐๐ฒ๐บ๐ผ๐ฟ๐ฟ๐ต๐ฎ๐ด๐ฒ
โ ๐ช๐๐๐๐๐ + ๐ฐ ๐ป๐ + ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐
โฉ ๐๐ป๐๐ฒ๐ฝ๐ฎ๐ฟ๐๐๐บ ๐๐ฒ๐บ๐ผ๐ฟ๐ฟ๐ต๐ฎ๐ด๐ฒ
โ ๐ท๐๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐
โช ๐๐๐ฝ๐ฒ๐ฟ๐๐ฒ๐ป๐๐ถ๐๐ฒ ๐๐ถ๐๐ผ๐ฟ๐ฑ๐ฒ๐ฟ๐ ๐ผ๐ณ ๐ฃ๐ฟ๐ฒ๐ด๐ป๐ฎ๐ป๐ฐ๐
โ ๐ฎ๐๐๐๐๐๐๐๐๐๐ ๐ฏ๐ป๐ต + ๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐
๐ฌ ๐ฃ๐๐ง๐๐ข๐๐ข๐๐ฌ
โซ ๐ก๐ฒ๐ผ๐ฝ๐น๐ฎ๐๐ถ๐ฎ & ๐ง๐๐บ๐ผ๐ฟ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ฟ๐
โ ๐ฏ๐๐๐๐๐๐๐๐ + ๐๐๐๐๐ ๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐
โฌ ๐๐ฒ๐น๐น ๐๐ป๐ท๐๐ฟ๐ & ๐๐ฝ๐ผ๐ฝ๐๐ผ๐๐ถ๐
โ ๐น๐๐๐๐๐๐๐๐๐ / ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐
๐ ๐ฃ๐๐๐ฅ๐ ๐๐๐ข๐๐ข๐๐ฌ
โญ ๐๐๐๐ผ๐ป๐ผ๐บ๐ถ๐ฐ ๐ก๐ฒ๐ฟ๐๐ผ๐๐ ๐ฆ๐๐๐๐ฒ๐บ ๐๐ฟ๐๐ด๐
โ ๐บ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ ๐๐๐๐
โฎ ๐๐ป๐๐ถ๐ต๐๐ฝ๐ฒ๐ฟ๐๐ฒ๐ป๐๐ถ๐๐ฒ ๐๐ฟ๐๐ด๐
โ ๐ซ๐๐๐ ๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐ + ๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐
โโโโโโโโโโโโโโโโโโ
๐ฏ ๐๐ข๐ช ๐ง๐ข ๐ฅ๐๐ฉ๐๐ฆ๐ ๐ง๐๐๐ฆ๐ ๐ญ๐ฑ
โ ๐ฆ๐ต๐ผ๐ฟ๐ ๐ก๐ผ๐๐ฒ๐ โ ๐ฏ๐ฌโ๐ฐ๐ฑ ๐บ๐ถ๐ป/topic
โ ๐ฃ๐ฌ๐ค๐ โ ๐๐บ๐บ๐ฒ๐ฑ๐ถ๐ฎ๐๐ฒ๐น๐ ๐ฎ๐ณ๐๐ฒ๐ฟ ๐ฟ๐ฒ๐๐ถ๐๐ถ๐ผ๐ป
โ ๐๐ฐ๐๐ถ๐๐ฒ ๐ฅ๐ฒ๐ฐ๐ฎ๐น๐น โ ๐ช๐ถ๐๐ต๐ผ๐๐ ๐น๐ผ๐ผ๐ธ๐ถ๐ป๐ด ๐ฎ๐ ๐ป๐ผ๐๐ฒ๐
โ ๐๐ผ๐ปโ๐ ๐๐๐ฎ๐ฟ๐ ๐ป๐ฒ๐ ๐น๐ผ๐-๐๐ถ๐ฒ๐น๐ฑ ๐๐ผ๐ฝ๐ถ๐ฐ๐
๐ ๐ฅ๐ฒ๐๐ถ๐๐ถ๐ ๐บ๐ถ๐๐๐ฎ๐ธ๐ฒ๐ ๐ฏ๐ฒ๐ณ๐ผ๐ฟ๐ฒ ๐๐น๐ฒ๐ฒ๐ฝ๐ถ๐ป๐ด
๐ฅ ๐ญ๐ฑ ๐ง๐ข๐ฃ๐๐๐ฆ. ๐ข๐ก๐ ๐ฆ๐๐ง.
โญ ๐ ๐๐ซ๐๐ ๐จ๐ ๐ฅ๐๐ฉ๐๐ฆ๐๐ข๐ก ๐ฉ๐๐๐จ๐.
๐ ๐ฆ๐๐ฉ๐ ๐ง๐๐๐ฆ ๐ฃ๐ข๐ฆ๐ง
๐ฅ ๐๐๐ฅ๐๐๐๐๐๐จ๐ ๐๐๐ฆ๐๐ข๐จ๐ก๐ง ๐๐ข๐๐ โ ๐ ๐๐๐๐๐๐ง๐ฅ (10% OFF)๐ฅ
๐ฏ ๐ฏ๐ฐ๐ฎ๐ฏ-๐๐ฐ๐ฌ๐ณ๐ซ ๐น๐ฌ๐ฝ๐ฐ๐บ๐ฐ๐ถ๐ต ๐บ๐ฌ๐น๐ฐ๐ฌ๐บ
๐ ๐ฆ๐๐ง ๐ญ/๐ณ โ ๐ญ๐ฑ ๐ ๐จ๐ฆ๐ง-๐ฅ๐๐ฉ๐๐ฆ๐ ๐ง๐ข๐ฃ๐๐๐ฆ
โโโโโโโโโโโโโโโโโโ
๐ซ ๐๐๐ก๐๐ฅ๐๐ ๐ ๐๐๐๐๐๐ก๐
โ ๐๐๐ + ๐๐ฟ๐ฟ๐ต๐๐๐ต๐บ๐ถ๐ฎ๐
โ ๐ฌ๐ช๐ฎ ๐๐๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐ / ๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐
โก ๐๐๐ฆ + ๐ ๐๐ผ๐ฐ๐ฎ๐ฟ๐ฑ๐ถ๐ฎ๐น ๐๐ป๐ณ๐ฎ๐ฟ๐ฐ๐๐ถ๐ผ๐ป
โ ๐ฌ๐ช๐ฎ ๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐
โข ๐๐ฒ๐ฎ๐ฟ๐ ๐๐ฎ๐ถ๐น๐๐ฟ๐ฒ
โ ๐๐๐ฟ๐๐ / ๐๐๐ฝ๐๐ + ๐ฑ๐ฟ๐๐ด๐ + ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐
โฃ ๐ฉ๐ฎ๐น๐๐๐น๐ฎ๐ฟ ๐๐ฒ๐ฎ๐ฟ๐ ๐๐ถ๐๐ฒ๐ฎ๐๐ฒ
โ ๐ด๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐
โค ๐ฆ๐๐ฟ๐ผ๐ธ๐ฒ + ๐๐ผ๐ฐ๐ฎ๐น๐ถ๐๐ฎ๐๐ถ๐ผ๐ป
โ ๐จ๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐
๐ฉบ ๐ฆ๐จ๐ฅ๐๐๐ฅ๐ฌ
โฅ ๐ฆ๐ต๐ผ๐ฐ๐ธ + ๐๐น๐๐ถ๐ฑ & ๐๐น๐ฒ๐ฐ๐๐ฟ๐ผ๐น๐๐๐ฒ ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐
โ ๐ป๐๐๐๐ ๐๐ ๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐๐
โฆ ๐ง๐ฟ๐ฎ๐๐บ๐ฎ + ๐๐ง๐๐ฆ
โ ๐ท๐๐๐๐๐๐ ๐๐๐๐๐๐ + ๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐
โง ๐๐๐ฟ๐ป๐
โ ๐ป๐ฉ๐บ๐จ + ๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐๐๐
๐ฉ๐ปโโ๏ธ ๐ข๐๐ฆ๐ง๐๐ง๐ฅ๐๐๐ฆ & ๐๐ฌ๐ก๐๐๐๐ข๐๐ข๐๐ฌ
โจ ๐ฃ๐ผ๐๐๐ฝ๐ฎ๐ฟ๐๐๐บ ๐๐ฒ๐บ๐ผ๐ฟ๐ฟ๐ต๐ฎ๐ด๐ฒ
โ ๐ช๐๐๐๐๐ + ๐ฐ ๐ป๐ + ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐
โฉ ๐๐ป๐๐ฒ๐ฝ๐ฎ๐ฟ๐๐๐บ ๐๐ฒ๐บ๐ผ๐ฟ๐ฟ๐ต๐ฎ๐ด๐ฒ
โ ๐ท๐๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐
โช ๐๐๐ฝ๐ฒ๐ฟ๐๐ฒ๐ป๐๐ถ๐๐ฒ ๐๐ถ๐๐ผ๐ฟ๐ฑ๐ฒ๐ฟ๐ ๐ผ๐ณ ๐ฃ๐ฟ๐ฒ๐ด๐ป๐ฎ๐ป๐ฐ๐
โ ๐ฎ๐๐๐๐๐๐๐๐๐๐ ๐ฏ๐ป๐ต + ๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐
๐ฌ ๐ฃ๐๐ง๐๐ข๐๐ข๐๐ฌ
โซ ๐ก๐ฒ๐ผ๐ฝ๐น๐ฎ๐๐ถ๐ฎ & ๐ง๐๐บ๐ผ๐ฟ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ฟ๐
โ ๐ฏ๐๐๐๐๐๐๐๐ + ๐๐๐๐๐ ๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐
โฌ ๐๐ฒ๐น๐น ๐๐ป๐ท๐๐ฟ๐ & ๐๐ฝ๐ผ๐ฝ๐๐ผ๐๐ถ๐
โ ๐น๐๐๐๐๐๐๐๐๐ / ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐๐
๐ ๐ฃ๐๐๐ฅ๐ ๐๐๐ข๐๐ข๐๐ฌ
โญ ๐๐๐๐ผ๐ป๐ผ๐บ๐ถ๐ฐ ๐ก๐ฒ๐ฟ๐๐ผ๐๐ ๐ฆ๐๐๐๐ฒ๐บ ๐๐ฟ๐๐ด๐
โ ๐บ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐๐๐๐๐๐ ๐ ๐๐๐๐
โฎ ๐๐ป๐๐ถ๐ต๐๐ฝ๐ฒ๐ฟ๐๐ฒ๐ป๐๐ถ๐๐ฒ ๐๐ฟ๐๐ด๐
โ ๐ซ๐๐๐ ๐๐๐๐๐๐๐ + ๐๐๐๐๐๐๐๐๐๐ + ๐๐ ๐๐๐๐๐ ๐๐๐๐๐๐๐
โโโโโโโโโโโโโโโโโโ
๐ฏ ๐๐ข๐ช ๐ง๐ข ๐ฅ๐๐ฉ๐๐ฆ๐ ๐ง๐๐๐ฆ๐ ๐ญ๐ฑ
โ ๐ฆ๐ต๐ผ๐ฟ๐ ๐ก๐ผ๐๐ฒ๐ โ ๐ฏ๐ฌโ๐ฐ๐ฑ ๐บ๐ถ๐ป/topic
โ ๐ฃ๐ฌ๐ค๐ โ ๐๐บ๐บ๐ฒ๐ฑ๐ถ๐ฎ๐๐ฒ๐น๐ ๐ฎ๐ณ๐๐ฒ๐ฟ ๐ฟ๐ฒ๐๐ถ๐๐ถ๐ผ๐ป
โ ๐๐ฐ๐๐ถ๐๐ฒ ๐ฅ๐ฒ๐ฐ๐ฎ๐น๐น โ ๐ช๐ถ๐๐ต๐ผ๐๐ ๐น๐ผ๐ผ๐ธ๐ถ๐ป๐ด ๐ฎ๐ ๐ป๐ผ๐๐ฒ๐
โ ๐๐ผ๐ปโ๐ ๐๐๐ฎ๐ฟ๐ ๐ป๐ฒ๐ ๐น๐ผ๐-๐๐ถ๐ฒ๐น๐ฑ ๐๐ผ๐ฝ๐ถ๐ฐ๐
๐ ๐ฅ๐ฒ๐๐ถ๐๐ถ๐ ๐บ๐ถ๐๐๐ฎ๐ธ๐ฒ๐ ๐ฏ๐ฒ๐ณ๐ผ๐ฟ๐ฒ ๐๐น๐ฒ๐ฒ๐ฝ๐ถ๐ป๐ด
๐ฅ ๐ญ๐ฑ ๐ง๐ข๐ฃ๐๐๐ฆ. ๐ข๐ก๐ ๐ฆ๐๐ง.
โญ ๐ ๐๐ซ๐๐ ๐จ๐ ๐ฅ๐๐ฉ๐๐ฆ๐๐ข๐ก ๐ฉ๐๐๐จ๐.
๐ ๐ฆ๐๐ฉ๐ ๐ง๐๐๐ฆ ๐ฃ๐ข๐ฆ๐ง
๐ฅ ๐๐๐ฅ๐๐๐๐๐๐จ๐ ๐๐๐ฆ๐๐ข๐จ๐ก๐ง ๐๐ข๐๐ โ ๐ ๐๐๐๐๐๐ง๐ฅ (10% OFF)๐ฅ
โค4
๐ฉบ STOMACH PATHOLOGY โ ONE-LINERS
NEET PG โข FMGE โข INI-CET RAPID REVISION
Stomach Lesions โข Exam Buzzwords
H. pylori gastritis = Curved bacilli, urease positive, chronic active gastritis
Autoimmune (Type A) gastritis = Parietal cell antibodies, intrinsic factor deficiency, B12 deficiency
Menetrier disease = Giant rugal folds, protein-losing gastropathy, โ TGF-ฮฑ
ZollingerโEllison syndrome = Gastrinoma (duodenum/pancreas), โ gastrin, multiple ulcers
Gastric ulcer = NSAIDs, H. pylori, stress; clean-based, incisura angularis common
Duodenal ulcer = Gastrin excess (ZES), H. pylori; anterior wall, near pylorus
Stress (acute) ulcers = Curling (burns), Cushing (head injury), multiple superficial ulcers
Hypertrophic pyloric stenosis = Infants, projectile vomiting, โ pyloric canal, olive mass
Peptic stricture = Healing of chronic ulcers โ fibrosis and luminal narrowing
MALT lymphoma = H. pylori associated, low-grade B-cell lymphoma
Diffuse large B-cell lymphoma = Most common aggressive gastric lymphoma
Lauren classification = Intestinal type (gland-forming) > Diffuse type (signet ring cells)
Intestinal type adenocarcinoma = Atrophic gastritis โ intestinal metaplasia โ dysplasia
Diffuse type adenocarcinoma = E-cadherin (CDH1) loss, linitis plastica
Signet ring cell carcinoma = Mucin pushing nucleus to periphery, diffuse type
Hereditary diffuse gastric cancer = CDH1 mutation, lobular breast cancer association
Familial adenomatous polyposis = Fundic gland polyps, duodenal adenomas
Gastric polyps โ Fundic gland = Associated with FAP, usually multiple
Gastric polyps โ Hyperplastic = Chronic gastritis, H. pylori, bleeding common
Gastric polyps โ Adenomatous = Premalignant, intestinal type metaplasia
Menetrier vs Mรฉnรฉtrier mimic (ZES) = Menetrier (โ acid), ZES (โ acid)
CMV gastritis = Large cells with โowlโs eyeโ intranuclear inclusions
Portal hypertensive gastropathy = Mosaic snake-skin pattern in mucosa
Erosive gastritis = NSAIDs, alcohol, bile reflux; superficial erosions
Atrophic gastritis = Loss of glands, intestinal metaplasia, โ risk of carcinoma
Intestinal metaplasia = Goblet cells in gastric mucosa, precancerous lesion
Dysplasia in stomach = Low-grade โ architectural distortion; High-grade โ carcinoma in situ
Carcinoid tumor = ECL cell hyperplasia, MEN1 association
GIST (stomach) = c-KIT (CD117) positive, most common mesenchymal tumor
Pernicious anemia = IF deficiency โ B12 deficiency โ macrocytic anemia
Clinical Pearls
Gastric ulcer โ Pain after food
Duodenal ulcer โ Pain relieved by food / antacids
Atrophic gastritis โ High risk of adenocarcinoma
Menetrier โ Protein loss (edema, hypoalbuminemia)
Pernicious anemia โ B12 deficiency
Mnemonic โ Gastric Polyps
F โ H โ A
F = Fundic gland โ FAP
H = Hyperplastic โ H. pylori
A = Adenomatous โ Premalignant
High-Yield Summary
H. pylori โ Gastritis, Ulcer, MALT lymphoma, Adenocarcinoma
ZES โ โ Gastrin โ Multiple ulcers
CDH1 mutation โ Diffuse type adenocarcinoma
Intestinal metaplasia โ Precancerous
Pernicious anemia โ IF deficiency โ B12 deficiency
@marrowdailycore
@marrowdailycore
NEET PG โข FMGE โข INI-CET RAPID REVISION
Stomach Lesions โข Exam Buzzwords
H. pylori gastritis = Curved bacilli, urease positive, chronic active gastritis
Autoimmune (Type A) gastritis = Parietal cell antibodies, intrinsic factor deficiency, B12 deficiency
Menetrier disease = Giant rugal folds, protein-losing gastropathy, โ TGF-ฮฑ
ZollingerโEllison syndrome = Gastrinoma (duodenum/pancreas), โ gastrin, multiple ulcers
Gastric ulcer = NSAIDs, H. pylori, stress; clean-based, incisura angularis common
Duodenal ulcer = Gastrin excess (ZES), H. pylori; anterior wall, near pylorus
Stress (acute) ulcers = Curling (burns), Cushing (head injury), multiple superficial ulcers
Hypertrophic pyloric stenosis = Infants, projectile vomiting, โ pyloric canal, olive mass
Peptic stricture = Healing of chronic ulcers โ fibrosis and luminal narrowing
MALT lymphoma = H. pylori associated, low-grade B-cell lymphoma
Diffuse large B-cell lymphoma = Most common aggressive gastric lymphoma
Lauren classification = Intestinal type (gland-forming) > Diffuse type (signet ring cells)
Intestinal type adenocarcinoma = Atrophic gastritis โ intestinal metaplasia โ dysplasia
Diffuse type adenocarcinoma = E-cadherin (CDH1) loss, linitis plastica
Signet ring cell carcinoma = Mucin pushing nucleus to periphery, diffuse type
Hereditary diffuse gastric cancer = CDH1 mutation, lobular breast cancer association
Familial adenomatous polyposis = Fundic gland polyps, duodenal adenomas
Gastric polyps โ Fundic gland = Associated with FAP, usually multiple
Gastric polyps โ Hyperplastic = Chronic gastritis, H. pylori, bleeding common
Gastric polyps โ Adenomatous = Premalignant, intestinal type metaplasia
Menetrier vs Mรฉnรฉtrier mimic (ZES) = Menetrier (โ acid), ZES (โ acid)
CMV gastritis = Large cells with โowlโs eyeโ intranuclear inclusions
Portal hypertensive gastropathy = Mosaic snake-skin pattern in mucosa
Erosive gastritis = NSAIDs, alcohol, bile reflux; superficial erosions
Atrophic gastritis = Loss of glands, intestinal metaplasia, โ risk of carcinoma
Intestinal metaplasia = Goblet cells in gastric mucosa, precancerous lesion
Dysplasia in stomach = Low-grade โ architectural distortion; High-grade โ carcinoma in situ
Carcinoid tumor = ECL cell hyperplasia, MEN1 association
GIST (stomach) = c-KIT (CD117) positive, most common mesenchymal tumor
Pernicious anemia = IF deficiency โ B12 deficiency โ macrocytic anemia
Clinical Pearls
Gastric ulcer โ Pain after food
Duodenal ulcer โ Pain relieved by food / antacids
Atrophic gastritis โ High risk of adenocarcinoma
Menetrier โ Protein loss (edema, hypoalbuminemia)
Pernicious anemia โ B12 deficiency
Mnemonic โ Gastric Polyps
F โ H โ A
F = Fundic gland โ FAP
H = Hyperplastic โ H. pylori
A = Adenomatous โ Premalignant
High-Yield Summary
H. pylori โ Gastritis, Ulcer, MALT lymphoma, Adenocarcinoma
ZES โ โ Gastrin โ Multiple ulcers
CDH1 mutation โ Diffuse type adenocarcinoma
Intestinal metaplasia โ Precancerous
Pernicious anemia โ IF deficiency โ B12 deficiency
@marrowdailycore
@marrowdailycore
โค10๐3
๐ฅ PATHOLOGY โ THE LAST-MINUTE MUST KNOWS ๐งฌ
NEET PG mein Pathology ke ye high-yield spotters + one-liners miss mat karna ๐
โโโโโโโโโโโโโโโโโโ
๐ฌ HISTOPATHOLOGY SPOTTERS
๐ฉธ IRON DEFICIENCY ANAEMIA
โ Iron โข โ TIBC โข โ Ferritin โญ
๐ฉธ ANAEMIA OF CHRONIC DISEASE
โ TIBC โข โ Ferritin
๐งฌ ABETALIPOPROTEINAEMIA
Acanthocytes + Retinitis pigmentosa + Neurological signs
๐ฌ APML
Auer rods + DIC
t(15;17) โ PML-RARA โญ
๐ BURKITT LYMPHOMA
Starry-sky appearance + Jaw/abdominal mass
๐ฆ HODGKIN LYMPHOMA
Reed-Sternberg โ Owl-eye cells
Treatment โ ABVD
๐ฉธ G6PD DEFICIENCY
Bite cells + Heinz bodies
๐ฉธ HEREDITARY SPHEROCYTOSIS
Spherocytes + โ MCHC
โโโโโโโโโโโโโโโโโโ
๐ DIRECT HISTOLOGY HITS
๐ฆ Papillary Thyroid Carcinoma
Orphan Annie-eye nuclei + Psammoma bodies
๐ซ Chromophobe RCC
Plant-like cell membrane + Perinuclear halo
๐ฆด Ewing Sarcoma
Small round blue cells + EWSR1-FLI1
๐ Phyllodes Tumour
Leaf-like architecture
โโโโโโโโโโโโโโโโโโ
โก RAPID-FIRE RECALL
Auer rods โ APML
Starry sky โ Burkitt
Owl-eye cells โ Hodgkin
Bite cells + Heinz bodies โ G6PD
Spherocytes + โ MCHC โ Hereditary spherocytosis
Orphan Annie nuclei โ Papillary thyroid carcinoma
Leaf-like pattern โ Phyllodes tumour
โโโโโโโโโโโโโโโโโโ
๐ฏ SAVE THIS. REVISE THIS. SCORE FROM THIS.
๐ Cerebellum BTR Code: MAGICBTR (10 % ) OFF
NEET PG mein Pathology ke ye high-yield spotters + one-liners miss mat karna ๐
โโโโโโโโโโโโโโโโโโ
๐ฌ HISTOPATHOLOGY SPOTTERS
๐ฉธ IRON DEFICIENCY ANAEMIA
โ Iron โข โ TIBC โข โ Ferritin โญ
๐ฉธ ANAEMIA OF CHRONIC DISEASE
โ TIBC โข โ Ferritin
๐งฌ ABETALIPOPROTEINAEMIA
Acanthocytes + Retinitis pigmentosa + Neurological signs
๐ฌ APML
Auer rods + DIC
t(15;17) โ PML-RARA โญ
๐ BURKITT LYMPHOMA
Starry-sky appearance + Jaw/abdominal mass
๐ฆ HODGKIN LYMPHOMA
Reed-Sternberg โ Owl-eye cells
Treatment โ ABVD
๐ฉธ G6PD DEFICIENCY
Bite cells + Heinz bodies
๐ฉธ HEREDITARY SPHEROCYTOSIS
Spherocytes + โ MCHC
โโโโโโโโโโโโโโโโโโ
๐ DIRECT HISTOLOGY HITS
๐ฆ Papillary Thyroid Carcinoma
Orphan Annie-eye nuclei + Psammoma bodies
๐ซ Chromophobe RCC
Plant-like cell membrane + Perinuclear halo
๐ฆด Ewing Sarcoma
Small round blue cells + EWSR1-FLI1
๐ Phyllodes Tumour
Leaf-like architecture
โโโโโโโโโโโโโโโโโโ
โก RAPID-FIRE RECALL
Auer rods โ APML
Starry sky โ Burkitt
Owl-eye cells โ Hodgkin
Bite cells + Heinz bodies โ G6PD
Spherocytes + โ MCHC โ Hereditary spherocytosis
Orphan Annie nuclei โ Papillary thyroid carcinoma
Leaf-like pattern โ Phyllodes tumour
โโโโโโโโโโโโโโโโโโ
๐ฏ SAVE THIS. REVISE THIS. SCORE FROM THIS.
๐ Cerebellum BTR Code: MAGICBTR (10 % ) OFF
โค7๐1
โญโโโ ๐ฉบ PSM UPDATES 2026 โโโโฎ
PART 1 โข NEET PG ๐ญ
โฐโโโโโโโโโโโโโโโโโโโโโฏ
๐ฉธ ANEMIA MUKT BHARAT
7 ร 7 ร 7 ๐ฅ
7 BENEFICIARIES
โข 6โ59 months
โข 5โ9 years
โข Adolescents 10โ19 yr
โข WRA 20โ49 yr
โข Pregnant women
โข Lactating women
โข LBW infants 0โ6 months
7 INTERVENTIONS
๐ IFA prophylaxis
๐ชฑ Biannual deworming
๐ข T4 โ Test โข Treat โข Talk โข Track
๐ฉธ Digital/POC testing
๐ฝ๏ธ IFA-fortified foods
๐ Non-nutritional causes
๐ฅ โEating Rightโ approach
7 INSTITUTIONAL MECHANISMS
๐๏ธ Inter-ministerial coordination
๐ฆ IFA + deworming supply chain
๐ซ School/Anganwadi testing
๐๏ธ VHSND convergence
๐ค Jan Chetna
๐ฑ Digital tracking
โ JANANI + RBSK + U-WIN
๐ถ SAMAGRA SHISHU BAL SWASTHYA
๐ฏ Theme: Complete care in first 3 years
HBNC + HBYC โ ONE PLATFORM
โ ๏ธ Risk groups โ LBW โข SAM โข Prematurity
๐ถ At-risk newborn
โ 9 visits / first 42 days
๐ง At-risk toddler
โ 8 extra visits till 36 months
๐ฉโโ๏ธ ASHA + CHO + ANM + AWW
๐ฑ Child Apps
JANANI โ Maternal/delivery
U-WIN โ Immunisation
POSHAN Tracker โ Nutrition
RBSK 2.0 โ Screening/referral
๐ฑ JANANI APP
Journey of Antenatal, Natal & Neonatal Integrated Care
๐คฐ ANC โ Delivery โ PNC โ Newborn
๐ท๏ธ โSehat ke Sath, Every Step of Careโ
๐ U-WIN + POSHAN Tracker
๐คฐ SUMAN ROADMAP 2030
๐ 29 June 2026
๐๏ธ MoHFW
๐งฉ RMNCAH + N
๐ฏ MMR <70/100,000 LB by 2030
๐ฅ Remember:
โข Life-cycle approach
โข 4-stage high-risk pregnancy care
โข 130 districts / 13 high-focus states
โข Jan Bhagidari
โข SDG 2030
๐ง RBSK 2.0
๐ 3 May 2026
๐ฅ 38 health conditions
THE CLASSIC 4Ds
Defects at birth
Diseases
Deficiencies
Developmental delays
๐ฑ Digital health cards
โก Real-time tracking
๐ถ Birth โ 18 years
๐ชช ABHA
Ayushman Bharat Health Account
โ Unique digital health ID
โ Store โข Access โข Share health records
๐ค KHUSHI AI
โKhushi โ Aapki E-Sanginiโ
๐ TB Mukt Bharat App
๐ 24 March 2026
๐ 12 Indian languages
๐๏ธ Voice interaction
๐ Pill reminders
๐ Clinic finder
๐ค Health-worker connection
๐ซ TB MUKT BHARAT APP
๐ฅ Khushi AI
โฐ Treatment reminders
๐ GPS facility finder
๐ฅ Ni-kshay Mitra tracking
๐ Provider dashboard
๐ Treatment adherence
๐ BPaLM REGIMEN
๐ฅ MDR/RR-TB
Bedaquiline
Pretomanid
Linezolid
Moxifloxacin
โฑ๏ธ 6 MONTHS
๐ค >14 years
๐ซ CNS / osteoarticular / miliary TB excluded
โโโโโโโโโโโโโโโโโโ
๐ญ SAVE โข SHARE โข REVISE
PSM UPDATES 2026 | PART 1/3
โโโโโโโโโโโโโโโโโโ
https://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
PART 1 โข NEET PG ๐ญ
โฐโโโโโโโโโโโโโโโโโโโโโฏ
๐ฉธ ANEMIA MUKT BHARAT
7 ร 7 ร 7 ๐ฅ
7 BENEFICIARIES
โข 6โ59 months
โข 5โ9 years
โข Adolescents 10โ19 yr
โข WRA 20โ49 yr
โข Pregnant women
โข Lactating women
โข LBW infants 0โ6 months
7 INTERVENTIONS
๐ IFA prophylaxis
๐ชฑ Biannual deworming
๐ข T4 โ Test โข Treat โข Talk โข Track
๐ฉธ Digital/POC testing
๐ฝ๏ธ IFA-fortified foods
๐ Non-nutritional causes
๐ฅ โEating Rightโ approach
7 INSTITUTIONAL MECHANISMS
๐๏ธ Inter-ministerial coordination
๐ฆ IFA + deworming supply chain
๐ซ School/Anganwadi testing
๐๏ธ VHSND convergence
๐ค Jan Chetna
๐ฑ Digital tracking
โ JANANI + RBSK + U-WIN
๐ถ SAMAGRA SHISHU BAL SWASTHYA
๐ฏ Theme: Complete care in first 3 years
HBNC + HBYC โ ONE PLATFORM
โ ๏ธ Risk groups โ LBW โข SAM โข Prematurity
๐ถ At-risk newborn
โ 9 visits / first 42 days
๐ง At-risk toddler
โ 8 extra visits till 36 months
๐ฉโโ๏ธ ASHA + CHO + ANM + AWW
๐ฑ Child Apps
JANANI โ Maternal/delivery
U-WIN โ Immunisation
POSHAN Tracker โ Nutrition
RBSK 2.0 โ Screening/referral
๐ฑ JANANI APP
Journey of Antenatal, Natal & Neonatal Integrated Care
๐คฐ ANC โ Delivery โ PNC โ Newborn
๐ท๏ธ โSehat ke Sath, Every Step of Careโ
๐ U-WIN + POSHAN Tracker
๐คฐ SUMAN ROADMAP 2030
๐ 29 June 2026
๐๏ธ MoHFW
๐งฉ RMNCAH + N
๐ฏ MMR <70/100,000 LB by 2030
๐ฅ Remember:
โข Life-cycle approach
โข 4-stage high-risk pregnancy care
โข 130 districts / 13 high-focus states
โข Jan Bhagidari
โข SDG 2030
๐ง RBSK 2.0
๐ 3 May 2026
๐ฅ 38 health conditions
THE CLASSIC 4Ds
Defects at birth
Diseases
Deficiencies
Developmental delays
๐ฑ Digital health cards
โก Real-time tracking
๐ถ Birth โ 18 years
๐ชช ABHA
Ayushman Bharat Health Account
โ Unique digital health ID
โ Store โข Access โข Share health records
๐ค KHUSHI AI
โKhushi โ Aapki E-Sanginiโ
๐ TB Mukt Bharat App
๐ 24 March 2026
๐ 12 Indian languages
๐๏ธ Voice interaction
๐ Pill reminders
๐ Clinic finder
๐ค Health-worker connection
๐ซ TB MUKT BHARAT APP
๐ฅ Khushi AI
โฐ Treatment reminders
๐ GPS facility finder
๐ฅ Ni-kshay Mitra tracking
๐ Provider dashboard
๐ Treatment adherence
๐ BPaLM REGIMEN
๐ฅ MDR/RR-TB
Bedaquiline
Pretomanid
Linezolid
Moxifloxacin
โฑ๏ธ 6 MONTHS
๐ค >14 years
๐ซ CNS / osteoarticular / miliary TB excluded
โโโโโโโโโโโโโโโโโโ
๐ญ SAVE โข SHARE โข REVISE
PSM UPDATES 2026 | PART 1/3
โโโโโโโโโโโโโโโโโโ
https://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
โค6
Marrow Daily Core
โญโโโ ๐ฉบ PSM UPDATES 2026 โโโโฎ PART 1 โข NEET PG ๐ญ โฐโโโโโโโโโโโโโโโโโโโโโฏ ๐ฉธ ANEMIA MUKT BHARAT 7 ร 7 ร 7 ๐ฅ 7 BENEFICIARIES โข 6โ59 months โข 5โ9 years โข Adolescents 10โ19 yr โข WRA 20โ49 yr โข Pregnant women โข Lactating women โข LBW infants 0โ6 months 7 INTERVENTIONSโฆ
โญโโโ ๐ฉบ PSM UPDATES 2026 โโโโฎ
PART 2 โข NEET PG ๐ญ
โฐโโโโโโโโโโโโโโโโโโโโโฏ
๐ WHO DRUG-SENSITIVE TB
๐ฅ New regimen:
2HPZM / 2HPM
H โ Isoniazid
P โ Rifapentine
Z โ Pyrazinamide
M โ Moxifloxacin
โ ๏ธ NOT ADOPTED IN INDIA
๐ ADULT TB VACCINATION
๐ Trial basis
WHO GETS IT?
โฅ60 years
BMI <18 kg/mยฒ
TB in last 5 years
Close contacts
Diabetes
Tobacco users
๐ซ C/I โ Immunosuppressed
๐ฑ Tracking โ TB-WIN
๐ฆ LEPROSY MUKT BHARAT 2023โ27
๐ฏ Eradication โ 2027
๐ฅ ABSULS
Active ASHA-Based Surveillance
for Leprosy Suspects
๐ฑ Nikusth 2.0
โ Case + treatment + rehabilitation tracking
๐ Contact PEP
โ Single-dose Rifampicin
๐ฐ Disability rehabilitation surgery incentive
โ Up to โน12,000
๐ฏ NLEP TARGETS
๐ Prevalence โ <1/10,000
๐ New case detection โ <10/100,000
๐ Grade-2 disability โ <1/10 lakh
๐ Cure rate โ >90%
๐ฅ Leprosy Mukt Bharat โ 2027
๐ฆ KALA-AZAR
๐ฏ Elimination target โ 2027
โ Elimination target achieved
๐งฌ NACP PHASE-V
๐ฅ 5 CORE GOALS
โ New HIV infections 80%
โ AIDS mortality 80%
๐ซ Eliminate vertical HIV + syphilis
๐ฅ Universal STI/RTI services
โ Eliminate stigma & discrimination
๐๏ธ MISSION AIDS SURAKSHA
๐ฏ HIV control โ 1 December 2027
๐ฅ 95 โ 95 โ 99
95% โ Know HIV status
95% โ Diagnosed โ ART
99% โ On treatment โ Viral suppression
๐ Viral suppression
โ HIV RNA โค200 copies/mL
๐ฅ SURAKSHA SANKALP KARYASHALA
๐ 219 high-priority districts
๐ข SURAKSHIT PLUS
โ 95-95-99 achieved
โ 0 MTCT HIV + Syphilis + Hep B
โ HIV/Syphilis dual testing in 1st trimester
๐ข SURAKSHIT
โ All 95-95-99 achieved
๐ก SAKSHAM
โ 2/3 achieved
๐ด SANGHARSHSHEEL
โ โฅ1/3 achieved
๐งซ SCORTCH
S โ Syphilis
C โ CMV
O โ Other โ Zika โข Malaria โข HIV
R โ Rubella
T โ Toxoplasmosis
C โ Chickenpox / Varicella
H โ HSV
๐ฅ SCORTCH = UPDATED TORCH
โโโโโโโโโโโโโโโโโโ
๐ญ SAVE โข SHARE โข REVISE
PSM UPDATES 2026 | PART 2/3
โโโโโโโโโโโโโโโโโโ
https://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
PART 2 โข NEET PG ๐ญ
โฐโโโโโโโโโโโโโโโโโโโโโฏ
๐ WHO DRUG-SENSITIVE TB
๐ฅ New regimen:
2HPZM / 2HPM
H โ Isoniazid
P โ Rifapentine
Z โ Pyrazinamide
M โ Moxifloxacin
โ ๏ธ NOT ADOPTED IN INDIA
๐ ADULT TB VACCINATION
๐ Trial basis
WHO GETS IT?
โฅ60 years
BMI <18 kg/mยฒ
TB in last 5 years
Close contacts
Diabetes
Tobacco users
๐ซ C/I โ Immunosuppressed
๐ฑ Tracking โ TB-WIN
๐ฆ LEPROSY MUKT BHARAT 2023โ27
๐ฏ Eradication โ 2027
๐ฅ ABSULS
Active ASHA-Based Surveillance
for Leprosy Suspects
๐ฑ Nikusth 2.0
โ Case + treatment + rehabilitation tracking
๐ Contact PEP
โ Single-dose Rifampicin
๐ฐ Disability rehabilitation surgery incentive
โ Up to โน12,000
๐ฏ NLEP TARGETS
๐ Prevalence โ <1/10,000
๐ New case detection โ <10/100,000
๐ Grade-2 disability โ <1/10 lakh
๐ Cure rate โ >90%
๐ฅ Leprosy Mukt Bharat โ 2027
๐ฆ KALA-AZAR
๐ฏ Elimination target โ 2027
โ Elimination target achieved
๐งฌ NACP PHASE-V
๐ฅ 5 CORE GOALS
โ New HIV infections 80%
โ AIDS mortality 80%
๐ซ Eliminate vertical HIV + syphilis
๐ฅ Universal STI/RTI services
โ Eliminate stigma & discrimination
๐๏ธ MISSION AIDS SURAKSHA
๐ฏ HIV control โ 1 December 2027
๐ฅ 95 โ 95 โ 99
95% โ Know HIV status
95% โ Diagnosed โ ART
99% โ On treatment โ Viral suppression
๐ Viral suppression
โ HIV RNA โค200 copies/mL
๐ฅ SURAKSHA SANKALP KARYASHALA
๐ 219 high-priority districts
๐ข SURAKSHIT PLUS
โ 95-95-99 achieved
โ 0 MTCT HIV + Syphilis + Hep B
โ HIV/Syphilis dual testing in 1st trimester
๐ข SURAKSHIT
โ All 95-95-99 achieved
๐ก SAKSHAM
โ 2/3 achieved
๐ด SANGHARSHSHEEL
โ โฅ1/3 achieved
๐งซ SCORTCH
S โ Syphilis
C โ CMV
O โ Other โ Zika โข Malaria โข HIV
R โ Rubella
T โ Toxoplasmosis
C โ Chickenpox / Varicella
H โ HSV
๐ฅ SCORTCH = UPDATED TORCH
โโโโโโโโโโโโโโโโโโ
๐ญ SAVE โข SHARE โข REVISE
PSM UPDATES 2026 | PART 2/3
โโโโโโโโโโโโโโโโโโ
https://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
โค6
Marrow Daily Core
โญโโโ ๐ฉบ PSM UPDATES 2026 โโโโฎ PART 2 โข NEET PG ๐ญ โฐโโโโโโโโโโโโโโโโโโโโโฏ ๐ WHO DRUG-SENSITIVE TB ๐ฅ New regimen: 2HPZM / 2HPM H โ Isoniazid P โ Rifapentine Z โ Pyrazinamide M โ Moxifloxacin โ ๏ธ NOT ADOPTED IN INDIA ๐ ADULT TB VACCINATION ๐ Trial basis โฆ
โญโโโ ๐ฉบ PSM UPDATES 2026 โโโโฎ PART 3 โข NEET PG ๐ญ โฐโโโโโโโโโโโโโโโโโโโโโฏ
๐ SAYANA PRESS
๐ฅ Self-injectable contraceptive
DMPA โ 104 mg / 0.65 mL SC
๐ ANTARA 150 mg โ IM โ Provider
๐ SAYANA PRESS 104 mg โ SC โ Self/Provider ๐ Thigh / Abdomen โฑ๏ธ Every 3 months
๐๏ธ CERVICAL CANCER SCREENING
๐ฅ Self-collected hr-HPV
โ Negative โ ๐ Repeat after 3 years
๐ WHO ELIMINATION TARGET
90 โ 70 โ 90
๐ 90% vaccinated ๐ฌ 70% screened ๐ 90% diagnosed โ treated
๐ NATIONAL HPV VACCINATION CAMPAIGN 2026
๐ 28 Feb 2026 ๐ Ajmer, Rajasthan
๐ง Target: 14-year-old girls
girls turning 15 within 90 days
๐ Gardasil-4 โ HPV 6, 11, 16, 18
๐ Single dose 0.5 mL IM ๐ Left upper arm
๐ฅ Government health facilities โ๏ธ Parental consent mandatory ๐ฑ U-WIN registration
๐ฏ 90-day campaign โ UIP inclusion
๐ฅ SAKSHAM ANGANWADI & POSHAN 2.0
๐ฏ Pregnant + lactating women ๐ฏ Adolescent girls ๐ฏ Children 0โ6 years
๐ฅ Annual targets:
โ Stunting/malnutrition โ 2% โ Anaemia โ 3%
๐ Merged: POSHAN Abhiyaan + ICDS + Scheme for Adolescent Girls
๐ฑ POSHAN Tracker ๐ฑ Poshan Vatika ๐ Poshan Bhi Padhai Bhi ๐ฎ๐ณ Poshan Maah โ September
๐ฆ QDENGA โ DENGUE VACCINE
๐ TAK-003
๐งฌ Live attenuated ๐ฏ DEN 1, 2, 3, 4
๐ 2 ร 0.5 mL SC โฑ๏ธ 3 months apart ๐ค 4โ60 years
โญ Key clue: NO PRE-SCREENING REQUIRED
๐ DIGITAL CENSUS 2027
๐ฎ๐ณ FIRST COMPLETELY DIGITAL CENSUS
๐๏ธ Ministry โ Home Affairs
PHASE 1 ๐ Houselisting + Housing
PHASE 2 ๐ฅ Population Enumeration
๐ป 4 Digital Tools: โ House Listing Block Creator โ HLO Mobile App โ Self Enumeration Portal โ Census Management & Monitoring System
๐ DEMOGRAPHIC UPDATES
CBR โ 18.3 โ Bihar | โ A&N
CDR โ 6.4 โ Chhattisgarh | โ Chandigarh
IMR โ 24/1000 โ MP | โ Manipur
MMR โ 87/100,000 โ UP | โ Kerala
Lifetime maternal risk โ 0.18%
U5MR โ 29/1000 โ MP | โ Kerala
NMR โ 19/1000 โ MP | โ Kerala
Natural growth โ 1.19 โ Bihar | โ A&N
Sex ratio at birth โ 917 โ Chhattisgarh | โ Uttarakhand
๐ NFHS-6 | 2023โ24
๐ถ Stunting โ 29.3% ๐ถ Severe wasting โ 5.2% ๐ Full immunisation โ 87.1% ๐ฆ Rotavirus โ 36.4% โ 85.4%
โค๏ธ TFR โ 2.0 ๐ CPR โ 69.1% ๐คฐ ANC registration โ 95.9% ๐คฐ 1st trimester ANC โ 76.2% ๐ฅ Institutional delivery โ 90.6%
๐ IFA โฅ100 days โ 54.9% ๐ IFA โฅ180 days โ 37.8%
๐ฆ IXCHIQ โ CHIKUNGUNYA VACCINE
๐ฅ First chikungunya vaccine
๐ Live attenuated ๐ 0.5 mL IM ๐ค >18 years
โญ Single dose โ ~99% protective antibody response within 28 days
๐ 2026 HEALTH DAY THEMES
๐ฆ Leprosy โ Leprosy is curable, real challenge is stigma
๐๏ธ Cancer โ United by Unique
โ๏ธ Obesity โ 8 billion reasons to act on obesity
๐ซ TB โ Yes we can end TB: led by countries, powered by people
โค๏ธ Health โ Together for health. Stand with science.
๐ฆ Malaria โ Driven to end Malaria, now we can, now we must
๐ง Mental Health โ It is time to prioritise Mental Health in the Workplace
๐๏ธ AIDS โ Rethink, Rebuild, Rise
โโโโโโโโโโโโโโโโโโ ๐ฅ PSM UPDATES 2026 โ COMPLETE ๐ญ SAVE IT FOR LAST-MINUTE REVISION โโโโโโโโโโโโโโโโโโhttps://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
๐ SAYANA PRESS
๐ฅ Self-injectable contraceptive
DMPA โ 104 mg / 0.65 mL SC
๐ ANTARA 150 mg โ IM โ Provider
๐ SAYANA PRESS 104 mg โ SC โ Self/Provider ๐ Thigh / Abdomen โฑ๏ธ Every 3 months
๐๏ธ CERVICAL CANCER SCREENING
๐ฅ Self-collected hr-HPV
โ Negative โ ๐ Repeat after 3 years
๐ WHO ELIMINATION TARGET
90 โ 70 โ 90
๐ 90% vaccinated ๐ฌ 70% screened ๐ 90% diagnosed โ treated
๐ NATIONAL HPV VACCINATION CAMPAIGN 2026
๐ 28 Feb 2026 ๐ Ajmer, Rajasthan
๐ง Target: 14-year-old girls
girls turning 15 within 90 days
๐ Gardasil-4 โ HPV 6, 11, 16, 18
๐ Single dose 0.5 mL IM ๐ Left upper arm
๐ฅ Government health facilities โ๏ธ Parental consent mandatory ๐ฑ U-WIN registration
๐ฏ 90-day campaign โ UIP inclusion
๐ฅ SAKSHAM ANGANWADI & POSHAN 2.0
๐ฏ Pregnant + lactating women ๐ฏ Adolescent girls ๐ฏ Children 0โ6 years
๐ฅ Annual targets:
โ Stunting/malnutrition โ 2% โ Anaemia โ 3%
๐ Merged: POSHAN Abhiyaan + ICDS + Scheme for Adolescent Girls
๐ฑ POSHAN Tracker ๐ฑ Poshan Vatika ๐ Poshan Bhi Padhai Bhi ๐ฎ๐ณ Poshan Maah โ September
๐ฆ QDENGA โ DENGUE VACCINE
๐ TAK-003
๐งฌ Live attenuated ๐ฏ DEN 1, 2, 3, 4
๐ 2 ร 0.5 mL SC โฑ๏ธ 3 months apart ๐ค 4โ60 years
โญ Key clue: NO PRE-SCREENING REQUIRED
๐ DIGITAL CENSUS 2027
๐ฎ๐ณ FIRST COMPLETELY DIGITAL CENSUS
๐๏ธ Ministry โ Home Affairs
PHASE 1 ๐ Houselisting + Housing
PHASE 2 ๐ฅ Population Enumeration
๐ป 4 Digital Tools: โ House Listing Block Creator โ HLO Mobile App โ Self Enumeration Portal โ Census Management & Monitoring System
๐ DEMOGRAPHIC UPDATES
CBR โ 18.3 โ Bihar | โ A&N
CDR โ 6.4 โ Chhattisgarh | โ Chandigarh
IMR โ 24/1000 โ MP | โ Manipur
MMR โ 87/100,000 โ UP | โ Kerala
Lifetime maternal risk โ 0.18%
U5MR โ 29/1000 โ MP | โ Kerala
NMR โ 19/1000 โ MP | โ Kerala
Natural growth โ 1.19 โ Bihar | โ A&N
Sex ratio at birth โ 917 โ Chhattisgarh | โ Uttarakhand
๐ NFHS-6 | 2023โ24
๐ถ Stunting โ 29.3% ๐ถ Severe wasting โ 5.2% ๐ Full immunisation โ 87.1% ๐ฆ Rotavirus โ 36.4% โ 85.4%
โค๏ธ TFR โ 2.0 ๐ CPR โ 69.1% ๐คฐ ANC registration โ 95.9% ๐คฐ 1st trimester ANC โ 76.2% ๐ฅ Institutional delivery โ 90.6%
๐ IFA โฅ100 days โ 54.9% ๐ IFA โฅ180 days โ 37.8%
๐ฆ IXCHIQ โ CHIKUNGUNYA VACCINE
๐ฅ First chikungunya vaccine
๐ Live attenuated ๐ 0.5 mL IM ๐ค >18 years
โญ Single dose โ ~99% protective antibody response within 28 days
๐ 2026 HEALTH DAY THEMES
๐ฆ Leprosy โ Leprosy is curable, real challenge is stigma
๐๏ธ Cancer โ United by Unique
โ๏ธ Obesity โ 8 billion reasons to act on obesity
๐ซ TB โ Yes we can end TB: led by countries, powered by people
โค๏ธ Health โ Together for health. Stand with science.
๐ฆ Malaria โ Driven to end Malaria, now we can, now we must
๐ง Mental Health โ It is time to prioritise Mental Health in the Workplace
๐๏ธ AIDS โ Rethink, Rebuild, Rise
โโโโโโโโโโโโโโโโโโ ๐ฅ PSM UPDATES 2026 โ COMPLETE ๐ญ SAVE IT FOR LAST-MINUTE REVISION โโโโโโโโโโโโโโโโโโhttps://whatsapp.com/channel/0029VanTshI0LKZAZreeWS46
โค7
Those who are going to give NEETPG 2026 must go through this Message
https://whatsapp.com/channel/0029VbCcF2iFCCoTeLTQts0h/365
https://whatsapp.com/channel/0029VbCcF2iFCCoTeLTQts0h/365
โค1